Fact CheckerSign in

NCT05015660Recruiting

Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing

LEFT Bundle Pacing vs Standard Right Ventricular Pacing for Heart Failure

Source: ClinicalTrials.gov · Last updated 11 Mar 2026

Brief summary (registry, in English)

High burden right ventricular (RV) pacing has been shown to increase cardiovascular mortality, incidence of heart failure (HF), worsen left ventricular (LV) function and accelerate the development of atrial fibrillation (AF). High percentage ventricular pacing and wider paced QRS in the setting of normal baseline LV ejection fractions have consistently been shown to be independent risk factors for pacing-induced cardiomyopathy. Left bundle branch pacing (LBBP) has emerged as a potential alternative pacing mechanism that may avoid LV dyssynchrony and pacing-induced LV dysfunction by mimicking native electrical conduction.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1300 (estimated)
First submitted
10 Aug 2021
Start date
1 Sept 2022
Primary completion date
1 Dec 2026
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
NCT number
NCT05015660

What you commit to

  • Study type: Interventional
  • Planned participants: 1300
  • From 1 Sept 2022 to the primary completion date, 1 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any prior attempt at implantation of an ICD, CRT, HBP, or LBBP

Age

  • Other serious medical condition with life expectancy of \<2 years

Other

  • Indication for an implantable cardioverter defibrillator
  • Presence of a mechanical tricuspid valve
  • Lack of capacity to consent
  • Pregnancy
  • Patients in whom the conduction system abnormality is expected to be transient or recover over time
  • Patients with permanent atrial fibrillation

Who the study is looking for

  • Age ≥ 18 years
  • Patients with an ejection fraction of \>35%
  • Patients with an indication for ventricular pacing and high-degree atrioventricular block where the degree of anticipated RV pacing is \>90% including:
    • Third degree AV block
    • Symptomatic or asymptomatic second-degree AV block
    • First degree AV block ≥ 280ms with a narrow QRS, or ≥ 240ms with an intraventricular delay (QRS duration ≥120ms)
  • Echocardiogram within the last 3 months, with ability to have DICOM images

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
McGill University Health Centre Research Institute
Coordinator of this site? Confirm its status
MontrealCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.